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Abstract
Background
In the UK, approximately 4,200 men who have sex with men (MSM) are living with HIV but
remain undiagnosed. Maximising the number of high-risk people testing for HIV is key to
ensuring prompt treatment and preventing onward infection. This study assessed how differ-
ent HIV test characteristics affect the choice of testing option, including remote testing (HIV
self-testing or HIV self-sampling), in the UK, a country with universal access to healthcare.
Methods and findings
Between 3 April and 11 May 2017, a cross-sectional online-questionnaire-based discrete
choice experiment (DCE) was conducted in which respondents who expressed an interest
in online material used by MSM were asked to imagine that they were at risk of HIV infection
and to choose between different hypothetical HIV testing options, including the option not
to test. A variety of different testing options with different defining characteristics were
described so that the independent preference for each characteristic could be valued. The
characteristics included where each test is taken, the sampling method, how the test is
obtained, whether infections other than HIV are tested for, test accuracy, the cost of the test,
the infection window period, and how long it takes to receive the test result. Participants
were recruited and completed the instrument online, in order to include those not currently
engaged with healthcare services. The main analysis was conducted using a latent class
model (LCM), with results displayed as odds ratios (ORs) and probabilities. The ORs indi-
cate the strength of preference for one characteristic relative to another (base) characteris-
tic. In total, 620 respondents answered the DCE questions. Most respondents reported that
they were white (93%) and were either gay or bisexual (99%). The LCM showed that there
were 2 classes within the respondent sample that appeared to have different preferences
for the testing options. The first group, which was likely to contain 86% of respondents, had
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a strong preference for face-to-face tests by healthcare professionals (HCPs) compared to
remote testing (OR 6.4; 95% CI 5.6, 7.4) and viewed not testing as less preferable than
remote testing (OR 0.10; 95% CI 0.09, 0.11). In the second group, which was likely to
include 14% of participants, not testing was viewed as less desirable than remote testing
(OR 0.56; 95% CI 0.53, 0.59) as were tests by HCPs compared to remote testing (OR 0.23;
95% CI 0.15, 0.36). In both classes, free remote tests instead of each test costing £30 was
the test characteristic with the largest impact on the choice of testing option. Participants in
the second group were more likely to have never previously tested and to be non-white than
participants in the first group. The main study limitations were that the sample was recruited
solely via social media, the study advert was viewed only by people expressing an interest
in online material used by MSM, and the choices in the experiment were hypothetical rather
than observed in the real world.
Conclusions
Our results suggest that preferences in the context we examined are broadly dichotomous.
One group, containing the majority of MSM, appears comfortable testing for HIV but prefers
face-to-face testing by HCPs rather than remote testing. The other group is much smaller,
but contains MSM who are more likely to be at high infection risk. For these people, the
availability of remote testing has the potential to significantly increase net testing rates, par-
ticularly if provided for free.
Author summary
Why was this study done?
• HIV testing remains low in high-risk populations, such as men who have sex with men
(MSM).
• HIV tests can be performed by healthcare professionals (HCPs) or remotely, using self-
testing and self-sampling kits.
• However, the relative importance of the test characteristics most likely to optimise their
use—such as the time it takes to receive a result and the cost of the tests—is not fully
understood.
What did the authors do and find?
• We assessed the strength of preference for different HIV test characteristics by asking
men in the UK who expressed an interest in online material used by MSM to complete
an online questionnaire.
• Participants were recruited using social media.
• Most respondents preferred to be tested by HCPs rather than to test remotely.
• The most important barrier to remote testing was its cost.
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PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002779 April 11, 2019 2 / 15
Competing interests: The authors have declared
that no competing interests exist.
Abbreviations: AIC, Akaike’s information criterion;
ASC, alternative-specific constant; CLOGIT,
conditional logit; CLS, condomless anal sex; DCE,
discrete choice experiment; HCP, healthcare
professional; HIVSS, HIV self-sampling; HIVST,
HIV self-testing; LCM, latent class model; MSM,
men who have sex with men; NHS, National Health
Service; OR, odds ratio; PrEP, pre-exposure
prophylaxis; RCT, randomised controlled trial; STI,
sexually transmitted infection.
What do these findings mean?
• In this study, HIV testing carried out by HCPs was found to be particularly valued by
respondents.
• There was some evidence that remote testing might increase testing rates, albeit for a
minority of respondents.
• Remote HIV testing should generally be viewed as supplementary to HCP-delivered
services.
Introduction
Although data show that there has been a steep decline in the incidence of HIV in some areas
of the world due to combination prevention [1], recent European surveillance data show that
the overall number of new HIV diagnoses has increased, particularly in men over the age of 50
years and among men who have sex with men (MSM) [2].
Guidelines produced by the World Health Organization [3] and other organisations [4]
suggest that MSM should test for HIV at least once a year, and more frequently if at higher risk
of infection. However, the rate at which MSM test for HIV in the UK remains sub-optimal [5],
with 1 survey suggesting that 25% of MSM had never tested and 55% had not tested within the
previous 12 months [6].
Reducing the time to diagnosis in people with HIV remains a key public health objective in
many countries as 60%–80% of all new HIV transmissions are estimated to derive from people
who are unaware of their infection status [7]. Moreover, late diagnosis continues to be associ-
ated with poorer health outcomes including premature death [8].
Over 80% of HIV tests taken by MSM in England are performed at UK specialist National
Health Service (NHS) sexual health services, although testing is available in many different set-
tings including general practice surgeries and community venues [9]. The UK legalised HIV
self-testing (HIVST) in April 2014, with the first commercial kit (Biosure) available to pur-
chase starting in 2015. In 2016, around 47,000 tests were performed using HIVST or HIV self-
sampling (HIVSS) kits, although not all by MSM [9]. Collectively, we refer to HIVST and
HIVSS as ‘remote testing’, but the key difference is that HIVSS kits need to be posted to a labo-
ratory for the test to be conducted and the result returned (often by phone if positive) at a later
date. For HIVST, there is no need to return a sample, as individuals perform the diagnostic
themselves and interpret their own result. Both types of kits have been shown to be acceptable
to people, including MSM [10,11]. In the UK, a number of local health authorities [12] and
non-governmental organisations currently provide HIVSS kits free of charge, but HIVST kits
are generally only available if purchased privately, at around £30 (around US$40) per kit.
The potential benefit of HIVSS and HIVST kits is that they could increase testing rates by
lowering individual and structural barriers to testing, or to testing as frequently as recom-
mended [10]. Indeed, these benefits have been demonstrated in randomised controlled trials
(RCTs) among MSM and other populations [13,14]. However, a disadvantage is that the rate
at which HIVSS kits are returned is sometimes low [15], and HIVST kits could lead to missed
opportunities for detection of common bacterial sexually transmitted infections (STIs) if their
use replaces regular clinic visits. Although this was not observed by Jamil et al. [13], Katz et al.
[16] recently reported significantly less STI testing by RCT participants randomised to HIVST.
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There is also concern that the time to confirmatory testing, treatment, and counselling might
be longer for people who receive a positive test result using HIVST, which requires the individ-
ual to initiate access to services, unlike testing using more traditional HCP-led services [17].
Last, the demand for remote testing options has generally remained low [18], meaning that the
extent to which MSM and other communities would prefer to use HIVST and HIVSS kits over
other testing options, or not testing, remains unclear. This extends to the kit characteristics
most likely to optimise their use [19]. For example, existing RCTs have provided HIVST kits
for free, meaning the impact of cost on the likelihood of testing is not fully understood [13,20].
We aimed to address this evidence gap by estimating how different test characteristics
could impact the uptake of remote testing (HIVSS and HIVST kits) and the overall probability
of testing among MSM in the UK. A further objective was to understand how preferences for
the different remote testing kits and other methods of HIV testing vary by sociodemographic
factors and risk levels.
Methods
This cross-sectional discrete choice experiment (DCE) required participants to complete a
questionnaire in which they were asked to imagine that ‘they had condomless anal sex with
someone whose HIV status they were unsure of’, prior to answering a series of questions (S1
Text) in which they were required to choose which of 3 options they preferred: a ‘remote HIV
test’, an ‘HIV test performed by a health care professional’, or ‘not to test’. The presented
options were described according to a number of characteristics (known as ‘attributes’) such
as how long it takes to get a result. Each attribute also had a number of ‘levels’, such as ‘in 10
minutes’ or ‘in 30 minutes’ for test results, that were varied by each question. The attribute lev-
els were all alternative specific, meaning that, say, the value of taking a blood sample via a skin
prick could differ depending on whether it was performed by a HCP or by the participants
themselves.
The underlying concept in a DCE is that participants choose the option with the most pref-
erable set of characteristics given the available choices. In this instance, the results indicate the
strength of preference for each HIV test characteristic and the likelihood that each testing
option is chosen, including the option of not testing. The method has its basis in random util-
ity theory [21]; thus, it has a robust theoretical basis and is an approach that has previously
been applied in a number of healthcare studies, including studies of HIV [22,23].
Choice of attributes and levels
The 8 attributes and associated levels were almost exclusively based on the findings of a recent
UK-based qualitative study involving 47 MSM [10] and the study group’s knowledge about the
design of existing sexual health services, including HIVST and HIVSS options, in the UK
(Table 1). Consideration was also given to the technical capabilities of existing and future
remote testing options, such as the infection window period (the time following exposure
before a test produces a reliable result). The qualitative study had been undertaken to inform
the design of a recent UK-based RCT of remote testing options and was therefore highly rele-
vant to our design needs, and basing DCE designs on qualitative study findings is also regarded
as good practice [24]. The maximum remote testing cost of £30 per test was chosen as this is
the current approximate retail price of HIVST kits in the UK.
The selected attributes and levels (Table 1) consisted of (1) testing location (remote testing:
1 level fixed at ‘somewhere convenient’; HCP testing: 4 levels), (2) sampling method (remote
testing: 2 levels; HCP testing: 2 levels), (3) how to obtain the test (remote testing: 2 levels; HCP
testing: 2 levels), (4) the inclusion of tests for bacterial STIs other than HIV (remote testing: 2
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levels; HCP testing: 2 levels), (5) test accuracy as a percentage (remote testing: 2 levels; HCP
testing: 2 levels), (6) test cost (remote testing: 4 levels; HCP testing: fixed at £0), (7) infection
window period (because the design already included an ‘accuracy’ attribute, the window
period was simply described as the time a person would have to wait before a test could be
taken—remote testing: 2 levels; HCP testing: fixed at 4 weeks), and (8) the waiting time for a
test result (remote testing: 4 levels; HCP testing: 4 levels). This final attribute combined infor-
mation on how the results were returned and how advice was accessed following a positive or
negative test result: These constructs were merged together because the level on one was condi-
tional on the value of another, meaning their independent effects could not be isolated. For
example, using an HIVSS kit means that results are returned after several days rather than
within a few minutes, and that advice about the result is available via the HCP who returns the
result. On the other hand, the use of an HIVST kit implies that results are obtained immedi-
ately, but that advice about the result is only available via online media or a free phone number
rather than from the person returning the sample results.
DCE instrument design
The instrument was designed using a D-efficient approach with 24 choice tasks (questions)
using Ngene software [25], ensuring that preferences for each of the attribute levels could be
independently assessed. However, the 24 DCE questions were divided into 2 sets of 12 DCE
questions to reduce the number of questions each participant needed to complete—a process
known as blocking [26].
Participants were also asked to provide information on sociodemographic and risk factors
including age (continuous variable), gender (male; transgender; other/prefer not to say), sexu-
ality (gay; bisexual; heterosexual/straight; prefer not to say), highest educational qualification
(none; O levels/GCSE [secondary education to age 16 years]; A levels [education to age 18
Table 1. The discrete choice experiment attributes and levels.
Attribute Label Remote testing HCP testing
Location of test Location Somewhere convenient such as your homea Sexual health clinicb; general practice; community location
such as an HIV charity; mobile clinic based at a bar, club, or
sauna
Sampling method Sample Oral swab; blood drop via a skin prickb Blood sample via syringeb; blood drop via a skin prick
How to obtain the test Obtain ‘Click and collect’ from a pharmacy or health clinicb; order
online and post
Drop in and waitb; book and attend an appointment
Also tests for infections
such as syphilis and
gonorrhoea
Infections HIV onlyb; all infections HIV onlyb; all infections
Test accuracy Accuracy A 95% chance the test result is accurateb; a 99% chance the test
result is accurate
A 95% chance the test result is accurateb; a 99% chance the test
result is accurate
Cost of test Cost £0; £10; £20; £30b £0a
Infection window period Window 4 weeksb; 12 weeks 4 weeksa
Wait for test results Result There and then in 10 minutes with advice online or via a free
phone numberb; there and then in 30 minutes with advice
online or via a free phone number; post sample and receive a
call in 3 days from a HCP and advice available from the HCP;
post sample and receive a call in 7 days from a HCP and
advice available from the the HCP
There and then in 10 minutes and advice available from the
HCPb; there and then in 30 minutes and advice available from
the HCP; receive a call the same day from a HCP and advice
available from the HCP; receive a call in 3 days from a HCP
and advice available from the HCP
aDenotes a fixed level, meaning its value is incorporated within the alternative-specific constant.
bBase category.
HCP, healthcare professional.
https://doi.org/10.1371/journal.pmed.1002779.t001
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years]; university degree or higher; other), ethnicity (white; black African; Asian; mixed race;
other), current HIV pre-exposure prophylaxis [PrEP] use (yes; no), condomless anal sex (CLS)
with a new or casual partner (never;<3 months ago; 3–6 months ago; 6 months–2 years ago;
2–5 years ago; 5+ years ago), ever previously tested for HIV (yes; no), and ever used an HIVST
or HIVSS kit (yes; no; unsure). The responses of the first 10 respondents were analysed to
ensure that participants understood the task and that the instrument produced logical results
(e.g., lower remote testing costs were preferred to higher costs). A further check for grammati-
cal errors and ambiguities in the text was also made at this point—none were identified.
Data collection
Between 3 April and 11 May 2017, participants were recruited via a paid advert placed on Face-
book for a total cost of £610, and explicitly aimed at a broad range of MSM. The advert was
presented only to men living in the UK who expressed an interest in online material used by
MSM. People who clicked on the embedded link were redirected to a webpage containing the
survey. All participants were required to state that they were at least 16 years old and without a
positive HIV diagnosis. No other exclusion criteria were applied. Individuals were offered the
chance to win a £50 voucher as an incentive to participate. Ethical approval for the study was
obtained from Brighton and Sussex Medical School (16/026/LLE) and the London School of
Hygiene & Tropical Medicine (11876). Participant informed consent was gathered by means
of an online tick box. The study protocol is provided as S1 Protocol. This study is reported as
per the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
guidelines (S1 Checklist).
Determining sample sizes in advance of conducting DCEs is difficult, not least because the
questionnaire design is unknown at the study’s outset. However, as it has been suggested that a
reasonable sample size is 300, we aimed to recruit at least 600 participants with complete
answers (2 × 300, given the blocking) [27].
Statistical analysis
All attribute levels were dummy-coded except when estimating the alternative-specific con-
stant (ASC), when effects coding was used in order to avoid confounding with the base level.
The 2 ASCs in this instance represent the extent to which respondents preferred ‘not to test’ or
‘HCP testing’ compared to ‘remote testing’, independently of the attribute levels. The results
are presented as odds ratios (ORs) relative to the relevant base category (Table 1) and the prob-
abilities of uptake for the remote testing option. Reported standard errors are adjusted in all
instances to account for the potential clustering in participant responses.
Many different models can be used to analyse DCE results, but following general advice, we
first used the most basic type—the conditional logit (CLOGIT) model [28] (see S1 Appendix).
Unlike in standard logistic regression, the results from CLOGIT models are ‘conditional’ on
the information relating to all the choice options as this information is grouped before analysis.
Here, for example, results for each completed question are represented by 3 rows of data, with
each containing the attribute levels for each choice (HCP testing, remote testing, and not test-
ing), with an additional variable indicating which of the 3 options was chosen. In this sense,
CLOGIT models are analogous to matched case–control approaches and investigate the rela-
tionship between a choice (case), options that were not chosen (controls), and a set of predic-
tive factors (attribute levels).
The CLOGIT model is the simplest form of analysis. Although it is recommended to be
used for the initial analysis [26], there are 2 main limitations with it. First, it includes the sim-
plifying ‘independence of irrelevant alternatives’ assumption. Under this assumption, the
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likelihood of choosing each option changes by the same proportion if any of them are omitted
from the analysis. However, this is unlikely to be realistic in our study since the HCP and
remote testing options are much more similar to each other (i.e., they both involve testing)
than the choice not to test. Second, the CLOGIT model produces results for the ‘average’ indi-
vidual, meaning that no allowance is made for the possibility that different groups of people
within the sample (e.g., different age groups) might have varying preferences—this is known
as ‘preference heterogeneity’.
As an alternative to the CLOGIT approach, we also analysed the results using a latent class
model (LCM), as it simultaneously relaxes the independence of irrelevant alternatives assump-
tion and allows potential preference heterogeneity to be examined. LCMs are specifically rec-
ommended if groups of respondents with similar preferences (here for testing options) are
anticipated.
LCMs assume there are subgroups of individuals (classes) with similar preferences, and that
the likelihood of class membership can be related to observed variables. The potential predic-
tors of class membership in this analysis were age (as a continuous variable), ethnicity (white;
non-white), currently taking PrEP (yes; no), educational qualification (none; GCSEs; A levels;
university degree or higher), and risk status (never tested for HIV and never had CLS; never
tested and previously had CLS; previously tested and never had CLS; previously tested and had
CLS). The number of classes in the LCM was based on minimisation of Akaike’s information
criterion (AIC) and the production of stable/meaningful standard errors. The CLOGIT and
LCM analyses were undertaken using Stata version 15 [29] and NLOGIT 5 [30], respectively.
Results
A total of 1,285 respondents clicked on the link and started to complete the survey. However,
618 did not complete the DCE questions, and 47 were excluded as they reported an HIV-posi-
tive diagnosis. The analysis sample therefore contained 620 participants. There was no evi-
dence to suggest that people who did versus did not complete the DCE questions differed in
terms of factors such as age (p = 0.69), self-reported sexual preference (p = 0.44), or ethnicity
(p = 0.44). However, there was evidence suggesting people with higher educational qualifica-
tions were more likely than those with lower or no educational qualifications to complete the
DCE questions (p< 0.001), to have tested for HIV at least once in the past (p< 0.001), and to
have used an HIVST or HIVSS kit (p = 0.001).
The mean age of the analysis sample was reported to be 31.1 years, and most respondents
stated they were white (93%) and were either gay or bisexual (99%) (Table 2). Almost 22% of
respondents reported they had never tested for HIV, and 3% were currently receiving PrEP. A
substantial proportion of participants chose the same testing option (203/620, 33%) for all 12
DCE questions, mainly testing by a HCP (166/620, 27%).
Model results
The signs on the coefficients from both the CLOGIT and LCM analyses were generally in the
expected direction, giving some reassurance as to the validity of both models. For example,
participants consistently preferred shorter to longer waiting times for test results and lower to
higher costs of buying a remote testing kit. Hereafter we only report the results of the LCM
analysis because, in addition to being the more theoretically appropriate model to use, it pre-
dicted a higher number of correct responses than the CLOGIT model: 77.6% versus 74.8%.
Thus, it was considered a better fit to the data.
The LCM identified 2 classes, with 86% and 14% of participants likely to be in classes 1 and
2, respectively—the standard errors became noticeably unstable if 3 or more classes were used,
Preferences for HIV testing services
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Table 2. Sample characteristics.
Characteristic Completed DCE questions
N = 620a
Did not complete DCE questions
N = 618a
p-Value
Age (years), mean [SE] 31.1 [0.47] 31.4 [0.60] 0.69b
Transgender identity 14 (2.3) 8 (1.8) 0.67c
Sexuality
Gay 528 (85.2) 376 (83.8)
Bisexual 84 (13.6) 61 (13.6)
Heterosexual 4 (0.7) 6 (1.3)
Prefer not to say 4 (0.7) 6 (1.3) 0.44d
Education
None 32 (5.2) 34 (7.6)
O levels/GCSE 91 (14.7) 126 (28.1)
A levels 174 (28.1) 114 (25.4)
University degree or higher 300 (48.4) 151 (33.6)
Other 23 (3.7) 24 (5.4) <0.001d
Ethnicity
White 574 (92.6) 421 (93.8)
Black African 7 (1.1) 2 (0.5)
Asian 19 (3.1) 9 (2.0)
Mixed race 20 (3.2) 17 (3.8) 0.44c
Ever tested for HIV
No 134 (21.6) 152 (37.8)
Yes 486 (78.4) 250 (62.2) <0.001d
Last tested for HIV
<3 months 160 (25.8) 63 (15.7)
3–6 months 104 (16.8) 40 (10.0)
6 months to 2 years 130 (21.0) 76 (18.9)
2 to 5 years 55 (8.9) 38 (9.5)
>5 years 34 (5.5) 30 (7.5)
Prefer not to say 3 (0.5) 3 (0.8)
Never 134 (21.6) 152 (37.8) <0.001c
Currently on PrEP
No 585 (97.0) 345 (96.1)
Yes 18 (3.0) 14 (3.9) 0.44d
Last condomless anal sex (CLS)
Never 135 (21.8) 104 (27.7)
<3 months 182 (29.4) 109 (29.0)
3–6 months 68 (11.0) 37 (9.8)
6 months to 2 years 100 (16.1) 49 (13.0)
>2 years 132 (21.3) 67 (17.8)
Prefer not to say 3 (0.5) 10 (2.7) 0.01c
Number of new or casual CLS partners in last year
None 295 (47.6) 191 (50.8)
1 149 (24.0) 97 (25.8)
2–4 129 (20.8) 64 (17.0)
5–10 25 (4.0) 14 (3.7)
>10 22 (3.6) 10 (2.7) 0.53d
Ever used an HIVST or HIVSS kit
(Continued)
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and the AIC increased. The ASCs showed that those in class 1 had a strong preference for
HCP testing compared to remote testing (OR 6.4; 95% CI 5.6, 7.4). They also viewed not test-
ing as undesirable compared to remote testing (OR 0.10; 95% CI 0.09, 0.11)—we refer to this
group as ‘pro HCP testers’ (Fig 1). Remote tests being free rather than £30 per test (OR 3.52;
95% CI 2.67, 4.63) was the largest predictor of the choice of test option (HCP, remote, or not
testing), although reductions to £10 (OR 1.86; 95% CI 1.33, 2.61) and £20 (OR 1.59; 95% CI
1.19, 2.14) were also valued. Other remote testing characteristics that were valued included kits
being 99% rather than 95% accurate (OR 1.35; 95% CI 1.08, 1.70) and using oral swabs rather
than a blood drop from a skin prick (OR 1.25; 95% CI 1.03, 1.52). However, a 12-week rather
than 4-week window period was strongly disliked (OR 0.43; 95% CI 0.35, 0.51), as were test
results being returned in 3 days rather than 10 minutes (OR 0.66; 95% CI 0.48, 0.90).
Table 2. (Continued)
Characteristic Completed DCE questions
N = 620a
Did not complete DCE questions
N = 618a
p-Value
No/unsure 462 (74.5) 335 (83.3)
Yes 158 (25.5) 67 (16.7) 0.001d
Values are number (percent) unless otherwise indicated.
aN may vary due to missing answers.
bt test.
cFisher’s exact test.
dChi-squared test.
DCE, discrete choice experiment; HIVSS, HIV self-sampling; HIVST, HIV self-testing; PrEP, pre-exposure prophylaxis.
https://doi.org/10.1371/journal.pmed.1002779.t002
Fig 1. HIV testing preferences—Results from the latent class model. Levels in parentheses denote the base category; levels with
the same base category are part of the same attribute. Odds ratios above 1 indicate a preference for the stated attribute level,
whereas values below 1 indicate a preference for the base category. �Odds ratios for the alternative-specific constants, which were
derived using effects coding. The alternative-specific constants indicate the strength of preference for no testing and HCP testing,
both compared to remote testing. GP, general practice; HCP, healthcare professional.
https://doi.org/10.1371/journal.pmed.1002779.g001
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In terms of HCP testing, class 1 members again expressed a preference for tests that were 99%
rather than 95% accurate (OR 1.45; 95% CI 1.20, 1.77) and tests for all listed infections rather than
just HIV (OR 1.47; 95% CI 1.19, 1.83). They also conveyed a dislike for tests at mobile clinics com-
pared with tests performed at sexual health clinics (OR 0.45; 95% CI 0.33, 0.61).
For class 2 members, not testing was viewed as less desirable than remote testing (OR 0.56;
95% CI 0.53, 0.59), as were tests by HCPs compared to remote testing (OR 0.23; 95% CI 0.15,
0.36). Similarly to class 1 members, those in class 2 expressed a preference for free remote tests
to those costing £30 (OR 2.0; 95% CI 1.18, 3.37). We refer to this group as ‘pro remote testers’.
Preferences for the remaining remote and HCP testing characteristics followed a similar pat-
tern to those of class 1 members, although in all cases the p-value associated with each OR was
>0.05.
Participants were more likely to be pro remote testers than pro HCP testers if they were cur-
rently taking PrEP (p = 0.007), compared to those who were not, or if they had never previ-
ously tested and never had CLS (p = 0.03) or had never previously tested and had CLS (p =
0.002), compared to those who had previously tested. However, respondents were more likely
to be pro HCP testers if they were white rather than non-white (p = 0.04). None of the remain-
ing characteristics were predictive of class membership (p> 0.05 in all instances).
The individual remote test characteristics altered the probability of preferring remote or
HCP testing to a greater or lesser extent, but had only a relatively small impact on the overall
probability of preferring not testing (Table 3). For example, reducing the remote test cost from
£30 (its base level) to £0 per kit increased the probability of preferring remote testing by 15.3%,
but the probability of preferring not testing only decreased by 2%. The main change associated
with the £0 cost of remote testing was a reduction in the probability of preferring HCP testing
by 13.3%.
Discussion
A DCE was conducted to assess MSM preferences for different HIV test characteristics. Partic-
ipants were recruited via social media using an advert directed at people who had expressed an
interest in online material used by MSM. The results from this study suggest that most MSM
Table 3. The predicted impact of changing remote test characteristics on the average probability of choosing different testing options, derived from the latent class
model.
Characteristic Base Percent change
Remote testing HCP testing No test
12-week infection window 4 weeks −8.8 7.7 1.0
Oral sample Skin prick 2.9 −2.4 −0.5
Order online and post Click and collect 0.8 −0.6 −0.2
Results in 7 days 10 minutes −2.1 1.8 0.3
Results in 3 days 10 minutes −4.1 3.5 0.6
Results in 30 minutes 10 minutes −0.5 0.4 0.1
99% accurate test 95% 3.5 −3.0 −0.5
Test for HIV and other infections HIV only 2.1 −1.8 −0.3
£0 per kit £30 15.3 −13.3 −2.0
£10 per kit £30 7.0 −5.8 −1.2
£20 per kit £30 4.4 −3.6 −0.8
Overall probability of choice: remote testing 21%, HCP testing 75%, and no test 4%.
HCP, healthcare professional.
https://doi.org/10.1371/journal.pmed.1002779.t003
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living in the UK are comfortable testing for HIV, but generally prefer face-to-face tests by
HCPs to using HIVST or HIVSS kits. Altering some of the remote test characteristics signifi-
cantly affected the likelihood of choosing either a remote or HCP testing approach, but gener-
ally had a small impact on the overall probability of not testing. This said, there appears to be a
minority of MSM for whom the availability of HIVST and HIVSS kits has the potential to sig-
nificantly increase the uptake and frequency of testing, which includes people at increased risk
of undetected infection.
Our results suggest that the main barrier to remote testing use was its purchase cost, fol-
lowed by the length of window period. Existing studies among MSM and other populations
have drawn similar conclusions [10,11,31–34], but our findings additionally suggest that most
people would still prefer HCP to remote testing even if the latter was free and available with a
4-week window period. This is because the majority of participants placed such a high value
on HCP testing over and above the specific test characteristics that we investigated. Our study
does not say why this is so, but others have previously highlighted the importance to MSM of
the general opportunity HCP testing affords for interaction with HCPs [35,36]. Given that the
majority of MSM preferred face-to-face testing services, although generally not at mobile clin-
ics, maintaining a mixed landscape of testing modalities is clearly of importance in ensuring
that their testing needs are met. Remote testing options in this context should therefore be
understood as supplementary to HCP-led services.
While HCP testing was generally preferred to remote testing, our LCM results support pre-
vious evidence [35] in showing that a minority (14%) of MSM prefer remote testing (pro
remote testers) to both HCP testing and not testing, meaning that it has the potential to
increase net testing frequency [13]. However, even for people who are likely to be in this
group, providing remote tests free rather than each costing £30 is likely to further increase
their use.
The analysis also showed that people who reported receiving PrEP generally preferred
remote testing, but in the absence of this option they preferred not to test than to be tested by a
HCP. At first glance this finding might be a concern, but, importantly, participants were asked
to choose whether and how they would prefer to test following CLS. Thus, given this context,
and that people on PrEP are advised to test regularly for HIV and other infections, it is plausi-
ble that respondents simply viewed additional HCP testing as unnecessary. In addition to
being more likely to be PrEP users, pro remote testers were more likely to be people who had
never previously tested for HIV and people who self-identified as being of non-white ethnicity.
These results are consistent with the existing evidence [35] and further suggest that remote
testing options could be effective methods of reaching people at high risk of infection who are
facing particularly elevated barriers to testing [37]. This includes black African MSM, who are
a priority group for intervention because they have a significantly higher HIV prevalence and
incidence than other groups [9].
Remote testing involves using either an HIVST or an HIVSS kit. The main advantage of
HIVST kits is that they provide results within a relatively short time period. However, some
are recommended for use 3 months after potential exposure, and they are not currently pro-
vided free by the UK NHS. Using the LCM results for HIVST and HIVSS kits respectively cost-
ing £30 and £0, providing results in 10 minutes and 7 days (the extreme options in the design),
and having a window period of 12 and 4 weeks shows that while participants continued to gen-
erally prefer tests by HCPs, they were more likely to choose to self-sample than self-test (likeli-
hood of choice: 37% versus 13%). Reducing the HIVST window period to 4 weeks increased
the probability of remote testing using an HIVST kit (37% versus 20%), but HIVST kits only
became more preferable than HIVSS kits when also provided free (40% versus 37%).
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Even though the general limitation that DCEs require participants to make hypothetical
rather than observed choices is acknowledged, there is growing evidence that they do predict
actual behaviour [38–40]. Participants were recruited via social media but because the advert
was only viewed by people expressing an interest in online material used by MSM, as identified
by the use of key words, the sample could have excluded men with concerns about disclosing
their sexual orientation, who may have the most pronounced HIV prevention needs [41].
Although this means there are potential limitations to the generalisability of our sample, previ-
ous research has shown that social media advertisements are capable of attracting MSM who
are less likely to report a gay identity, male-only partnerships, and recent HIV testing [42]. We
recruited a broad group of men who expressed an interest in gay online material on their Face-
book account. We acknowledge that sexual orientation identity is not always consistent with
behaviour or gender identity. In line with common use in the literature, our use of the term
MSM may include a minority of people who have never had sex with a man, who identify as
non-binary, or who have a heterosexual identity.
Another limitation with our study is the simplification of assessing concerns about test
accuracy, which was stated as the choice between a 95% and 99% accurate test. Because of this,
we are uncertain as to how particular issues around the sensitivity and specificity of the tests
could affect individuals’ preferences for testing. Participants were asked to complete the DCE
questions imagining they had recently had CLS. However, Witzel et al. suggest there are 2
other main reasons MSM might consider HIV testing: as reassurance when there is doubt or
anxiety related to HIV and in response to peer-related social norms [36]. Thus, finally, we
acknowledge that our results might not be generalizable to all contexts in which testing could
be contemplated.
There are also strengths to this study. Participants were recruited via social media advertise-
ments because of their wide national reach and common use by MSM [43] and to include peo-
ple who had not previously tested for HIV. Moreover, the composition of our sample is
broadly comparable to that of a recent large survey of MSM in the UK, suggesting it might be
representative of this population [44].
Conclusions
Ensuring that MSM test regularly for HIV is key to reducing late diagnosis and its associated
poorer health outcomes, higher costs, and further transmissions. While it is recognised that
the factors mediating the decisions of MSM about HIV testing are complex [35], our results
suggest that preferences in the context we examined are divided. One group, containing the
majority of MSM, appears comfortable testing for HIV but in nearly all circumstances they
prefer face-to-face testing by HCPs compared to using HIVST or HIVSS kits. The other group
is smaller in comparison but, importantly, contains MSM who are more likely to be at high
infection risk. For these people, the availability of and access to HIVST and HIVSS kits has the
potential to significantly increase net testing rates, especially if provided for free. We believe
that policy makers and commissioners should be attentive to these preferences, ensuring that a
wide mix of services is available to meet the diverse testing needs of MSM. This is a potentially
critical issue given the temptation to reduce the provision of more costly HCP-led testing ser-
vices in favour of remote testing options.
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